Magenta Medical
Self-Expanding Percutaneous Mechanical Circulatory Support
Company Overview
Snapshot
Founded in October 2012 by Ehud Schwammenthal and Yosi Tuval, Magenta Medical operates with 51–200 employees. The company has raised $224.9M across 5 funding rounds from 12 investors, with Novo Holdings leading a round in July 2024. In July 2024, Magenta Medical secured funding to advance FDA approval for its heart pump.
Business overview
Magenta Medical is a medical device company focused on developing catheter-mounted blood pumps for patients with acute heart failure. Its core product, the Elevate percutaneous Left Ventricular Assist Device, is a low-profile, high-flow arterial pump designed for temporary mechanical circulatory support during high-risk coronary interventions and for treating cardiogenic shock. The company operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices and Medical Treatment & Therapeutics markets, serving healthcare providers and chronic patients in North America and Europe.
Strategic signal
In July 2024, Magenta Medical secured significant funding led by. This development signals strong investor confidence in the company's innovative medical device technology and its potential to address critical needs in acute heart failure treatment, positioning Magenta Medical for accelerated market entry and expansion.
Log in to access full profile ›Company Intelligence Q&A
- What is Magenta Medical's primary product?
- Magenta Medical develops the Elevate percutaneous Left Ventricular Assist Device, a catheter-mounted blood pump designed for temporary mechanical circulatory support in patients with acute heart failure.
- When was Magenta Medical founded and by whom?
- Magenta Medical was founded in October 2012 by Ehud Schwammenthal and Yosi Tuval.
- What was a significant funding event for Magenta Medical in 2024?
- In July 2024, Magenta Medical secured funding led by.
- Which investors participated in Magenta Medical's May 2023 funding round?
- In May 2023, Magenta Medical received funding led by OrbiMed, with participation from.
- What is the current development stage of Magenta Medical's product?
- Magenta Medical's Elevate percutaneous Left Ventricular Assist Device is currently in clinical trials.